TNXP
Tonix Pharmaceuticals Holding Corp.
Next earnings Aug 10, 2026 · consensus $-2.88 EPS, $7.10M rev
Last earnings +0.1% on 2026-05-11
$11.98
▼ -0.99%$11.98▼ -62.98%
over 1Y
L $10.65EODHDH $61.57
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-1.0%
1W-0.2%
1M-6.2%
3M-12.9%
YTD-27.6%
1Y-63.0%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy
Revenue grew 29.8% YoY; but unprofitable (net margin -946.2%).
Tonix Pharmaceuticals Holding Corp. shows $13.1M in FY2025 revenue (+29.8% YoY), a -946.2% net margin, and -50.6% ROE.
Sources: SEC EDGAR (CIK 0001430306, latest 10-Q filed 2026-05-11) · EODHD · as of 6/26/2026, 10:11:05 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.